Correlation Between Travere Therapeutics and Sarepta Therapeutics

Can any of the company-specific risk be diversified away by investing in both Travere Therapeutics and Sarepta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Travere Therapeutics and Sarepta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Travere Therapeutics and Sarepta Therapeutics, you can compare the effects of market volatilities on Travere Therapeutics and Sarepta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Travere Therapeutics with a short position of Sarepta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Travere Therapeutics and Sarepta Therapeutics.

Diversification Opportunities for Travere Therapeutics and Sarepta Therapeutics

-0.02

Correlation Coefficient

Travere Therapeutics  Sarepta Therapeutics

Good diversification

The 3 months correlation between Travere and Sarepta is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Travere Therapeutics and Sarepta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sarepta Therapeutics and Travere Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Travere Therapeutics are associated (or correlated) with Sarepta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sarepta Therapeutics has no effect on the direction of Travere Therapeutics i.e., Travere Therapeutics and Sarepta Therapeutics go up and down completely randomly.

Pair Corralation between Travere Therapeutics and Sarepta Therapeutics

Given the investment horizon of 90 days Travere Therapeutics is expected to generate 1.39 times more return on investment than Sarepta Therapeutics. However, Travere Therapeutics is 1.39 times more volatile than Sarepta Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Sarepta Therapeutics is currently generating about 0.01 per unit of risk. If you would invest  1,427  in Travere Therapeutics on September 14, 2024 and sell it today you would earn a total of  364.00  from holding Travere Therapeutics or generate 25.51% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Travere Therapeutics  vs.  Sarepta Therapeutics

Travere Therapeutics

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Travere Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Travere Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Sarepta Therapeutics

Risk-Adjusted Performance

1 of 100

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Sarepta Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Sarepta Therapeutics is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Travere Therapeutics and Sarepta Therapeutics

The main advantage of trading using opposite Travere Therapeutics and Sarepta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Travere Therapeutics position performs unexpectedly, Sarepta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sarepta Therapeutics will offset losses from the drop in Sarepta Therapeutics' long position.

The idea behind Travere Therapeutics and Sarepta Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..